Market Place
Sourcing Support
Evoke Pharma, Inc. Reports Q3 2024 Financial Results
07 Nov 2024 //
GLOBENEWSWIRE
Evoke Pharma & Eversana Improvement in Gastroparesis Outcomes
28 Oct 2024 //
GLOBENEWSWIRE
Evoke Pharma Showcases Research at ACG Annual Meeting
23 Oct 2024 //
GLOBENEWSWIRE
Evoke Announces Appointment of Ben to Board of Directors
22 Oct 2024 //
GLOBENEWSWIRE
Evoke Pharma Announces Warrant Proceeds and Board Expansion
01 Oct 2024 //
GLOBENEWSWIRE
Evoke Pharma Reaffirms Commitment To Gastroparesis Patients
19 Sep 2024 //
GLOBENEWSWIRE
Evoke Pharma To Participate In GHAPP Annual Conference
09 Sep 2024 //
GLOBENEWSWIRE
Evoke Pharma To Present At H.C. Wainwright Conference
04 Sep 2024 //
GLOBENEWSWIRE
Evoke Pharma, Inc. Reports Second Quarter 2024 Financial Results
13 Aug 2024 //
GLOBENEWSWIRE
Evoke Pharma, Inc. Supports Gastroparesis Awareness Month
08 Aug 2024 //
GLOBENEWSWIRE
Evoke Pharma, Inc. Announces Reverse Stock Split
30 Jul 2024 //
GLOBENEWSWIRE
Evoke Pharma Reports Positive Momentum For GIMOTI Commercial Strategy
17 Jun 2024 //
GLOBENEWSWIRE
Evoke To Present GIMOTI Gastroparesis Care Insights At DDW 2024
16 May 2024 //
GLOBENEWSWIRE
Evoke Pharma Reports First Quarter 2024 Financial Results
14 May 2024 //
GLOBENEWSWIRE
Evoke Pharma to Host Virtual KOL Webinar on the Evolving Landscape
17 Apr 2024 //
GLOBENEWSWIRE
Evoke Announces Senior Leadership Transition with Promotion of Matthew to CEO
21 Mar 2024 //
GLOBENEWSWIRE
Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
14 Mar 2024 //
GLOBENEWSWIRE
Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results
07 Mar 2024 //
GLOBENEWSWIRE
Evoke Pharma Announces Closing of $7.5 Million Public Offering
14 Feb 2024 //
GLOBENEWSWIRE
Evoke Announces Pricing of Underwritten Public Offering of up to $30 Million
09 Feb 2024 //
GLOBENEWSWIRE
Evoke adopts new name and structure in simplification push
09 Jan 2024 //
FIERCE PHARMA
Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent
27 Nov 2023 //
GLOBENEWSWIRE
USPTO Grants Another Formulation Patent Covering GIMOTI
14 Nov 2023 //
GLOBENEWSWIRE
Evoke Pharma Reports Third Quarter 2023 Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
Evoke & EVERSANA Unveil Data Demonstrating Meaningfully Reduced Healthcare Costs
31 Oct 2023 //
GLOBENEWSWIRE
Evoke Pharma™s Abstract Compared to Metoclopramide in Reducing Healthcare Costs
18 Oct 2023 //
GLOBENEWSWIRE
Evoke Pharma Receives Notice of Allowance from USPTO for GIMOTI®
14 Sep 2023 //
GLOBENEWSWIRE
Evoke Pharma Reports Second Quarter 2023 Financial Results
10 Aug 2023 //
GLOBENEWSWIRE
Evoke Pharma and EVERSANA Announce Abstract Acceptance at 2023 ANMS
07 Aug 2023 //
GLOBENEWSWIRE
Evoke and Eversana Announce Abstract Selection for Plenary Oral Presentation
25 Jul 2023 //
GLOBENEWSWIRE
Evoke to Host Opinion Leader Webinar on Healthcare Resource Utilization Data
14 Jun 2023 //
GLOBENEWSWIRE
Evoke Pharma Reports First Quarter 2023 Financial Results
15 May 2023 //
GLOBENEWSWIRE
Real-World Data Presented by Evoke Pharma and EVERSANA at Digestive Disease 2023
09 May 2023 //
GLOBENEWSWIRE
Evoke Pharma€™s Real-World Healthcare Utilization Data Comparing GIMOTI®
04 May 2023 //
GLOBENEWSWIRE
New GIMOTI Patent Listed in FDA Orange Book
01 May 2023 //
GLOBENEWSWIRE
United States Patent and Trademark Office (USPTO) Grants Evoke Pharma
20 Apr 2023 //
GLOBENEWSWIRE
Evoke Pharma Receives Notice of Allowance from USPTO for GIMOTI-Related Patent
06 Apr 2023 //
GLOBENEWSWIRE
Evoke Pharma & EVERSANA Announce Compelling Real-World Data
23 Mar 2023 //
GLOBENEWSWIRE
Evoke Pharma Reports Fourth Quarter and Full Year 2022 Financial Results
21 Mar 2023 //
GLOBENEWSWIRE
Evoke Pharma to Report Fourth Quarter and Full Year 2022 Results on March 21
15 Mar 2023 //
GLOBENEWSWIRE
Evoke & EVERSANA Selected to Present Results of Healthcare Utilization Study
21 Feb 2023 //
GLOBENEWSWIRE
Evoke Announces Teva Ends Pursuit of Paragraph IV ANDA Against Gimoti
30 Jan 2023 //
GLOBENEWSWIRE
Evoke Pharma Announces Acceptance of an Abstract at AMCP Annual Meeting 2023
18 Jan 2023 //
GLOBENEWSWIRE
USPTO Grants New Patent to Evoke Pharma Covering the Usage of GIMOTI®
07 Dec 2022 //
GLOBENEWSWIRE
Evoke Pharma receives US patent for Gimoti nasal spray
02 Dec 2022 //
PHARMABIZ
Evoke Pharma Strengthens its Intellectual Property Portfolio a Notice Allowance
30 Nov 2022 //
GLOBENEWSWIRE
Evoke Pharma Reports Record Third Quarter 2022 Financial Results
09 Nov 2022 //
GLOBENEWSWIRE
Evoke Pharma to Report Third Quarter Results on November 9, 2022
02 Nov 2022 //
GLOBENEWSWIRE
Evoke to Participate in American College of Gastroenterology Annual Meeting
20 Oct 2022 //
GLOBENEWSWIRE
Evoke Pharma Receives Notice of Allowance from USPTO for a Patent to GIMOTI
20 Sep 2022 //
GLOBENEWSWIRE
Evoke Pharma Reports Second Quarter 2022 Financial Results
10 Aug 2022 //
GLOBENEWSWIRE
Evoke Pharma to Report Second Quarter Results on August 10, 2022
03 Aug 2022 //
GLOBENEWSWIRE
Evoke Pharma Recognizes Gastroparesis Awareness Month through Support of IFFGD
01 Aug 2022 //
GLOBENEWSWIRE
Evoke Pharma Expands IP Portfolio with Canadian Patent of GIMOTI Method of Use
06 Jul 2022 //
GLOBENEWSWIRE
Evoke Pharma Announces Approval of GIMOTI to Florida State Medicaid Program
15 Jun 2022 //
GLOBENEWSWIRE
Evoke Pharma Regains Compliance with Nasdaq Listing Requirements
08 Jun 2022 //
GLOBENEWSWIRE
Patient Experience Survey Reported Positive Findings for GIMOTI
18 May 2022 //
GLOBENEWSWIRE
Evoke Pharma to Present at H.C. Wainwright Global Investment Conference
17 May 2022 //
GLOBENEWSWIRE
Evoke Pharma Reports First Quarter 2022 Financial Results
10 May 2022 //
GLOBENEWSWIRE
Evoke Pharma to Report First Quarter 2022 Financial Results on May 10, 2022
03 May 2022 //
GLOBENEWSWIRE
